Market revenue in 2023 | USD 732.3 million |
Market revenue in 2030 | USD 1,504.1 million |
Growth rate | 10.8% (CAGR from 2023 to 2030) |
Largest segment | Botulinum toxin |
Fastest growing segment | Hyaluronic Acid |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hyaluronic Acid, Botulinum Toxin, Aquatic Light Injections |
Key market players worldwide | Ipsen SA, AbbVie Inc, Merz Pharma, Galderma Group AG Registered Shares, Prollenium Medical Technologies, Suneva Medical, Sinclair Pharma plc, Medytox, Revance Therapeutics Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to aesthetic injectable market will help companies and investors design strategic landscapes.
Botulinum toxin was the largest segment with a revenue share of 45.73% in 2023. Horizon Databook has segmented the Germany aesthetic injectable market based on hyaluronic acid, botulinum toxin, aquatic light injections covering the revenue growth of each sub-segment from 2018 to 2030.
Germany is one of the major countries spearheading the aesthetic injectable market. Various factors, such as an increase in the popularity of cosmetic procedures, technological advancements, and a rise in beauty consciousness, are driving the market.
Furthermore, rising urban population, novel product approvals, advancements in noninvasive procedures, and availability of skilled professionals are other factors expected to boost the market. However, the high cost of aesthetic procedures is likely to impede the market growth.
According to the ISAPS report, in 2022, over 496,785 injectable filler procedures were performed in Germany, of which 293,736 were botulinum toxin filler procedures, while nearly 7,000 procedures were related to CaHA.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany aesthetic injectable market, including forecasts for subscribers. This country databook contains high-level insights into Germany aesthetic injectable market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account